In a note to clients, Capital Economics said it now expects the key rate to end this year at 17%, rather than 18% previously. But it continues to expect the key rate to be 12% at the end of 2026, an ...

Arvinas and Pfizer have filed for U.S. Food and Drug Administration approval of their proposed breast-cancer drug vepdegestrant in certain patients with estrogen-receptor mutations.

U.S. stock-index futures (ES00) (YM00) (NQ00) are higher as benchmark Treasury yields BX:TMUBMUSD10Y dip. The dollar index DXY is up, while oil prices (CL.1) fall and gold (GC00) is trading around ...

Since the beginning of the year, the Polish stock market has been the best performer of any of the countries in the Barclays database. The iShares MSCI Poland ETF EPOL has produced a year-to-date ...